You just read:

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

News provided by

Eli Lilly and Company

Sep 25, 2017, 08:30 ET